Nutex health reports first quarter 2025 financial results

Total revenue of $211.8 million versus $67.5 million in q1 2024, an increase of 213.8% net income attributable to nutex health inc. of $14.6 million versus net loss of $0.4 million in q1 2024 diluted eps of $2.56 per share versus $(0.08) per share in q1 2024 ebitda of $43.1 million versus $7.1 million in ebitda in q1 2024, an increase of 507.0% adjusted ebitda of $72.8 million versus $(0.4) million in q1 2024 net cash from operating activities of $51.0 million company believes its arbitration efforts through the independent dispute resolution (idr) process have resulted in more fair and reasonable payments houston , may 13, 2025 /prnewswire/ -- nutex health inc. ("nutex health" or the "company") (nasdaq: nutx), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (hopds) in 11 states and primary care-centric, risk-bearing physician networks, today announced first quarter 2025 financial results for the three months ended march 31, 2025.
NUTX Ratings Summary
NUTX Quant Ranking